SCHEMBL2147169

SCHEMBL2147169

Cc1cc(Cl)cc(C)c1B(O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.40
CYP3A4 P08684 2/20 0.36
NOX1 Q9Y5S8 1/20 0.35
TSHR P16473 2/20 0.35
HTR2B P41595 2/20 0.35
CA2 P00918 1/20 0.35
LPL P06858 1/20 0.35
LIPG Q9Y5X9 1/20 0.35
CHRM1 P11229 1/20 0.35
ALOX15 P16050 1/20 0.35
MAOA P21397 1/20 0.35
TBXA2R P21731 1/20 0.35
ADRA1A P35348 1/20 0.35
RAPGEF4 Q8WZA2 1/20 0.34
CYP2A6 P11509 1/20 0.34
AHR P35869 1/20 0.34
GAA P10253 1/20 0.33
ALOX5 P09917 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30905945 0.88 RAPGEF4 (0.39) ENPP2CYP3A4TSHRHTR2BCHRM1
SCHEMBL29955565 0.86 ALDH1A1 (0.38) ENPP2CYP3A4TSHRHTR2BCHRM1
SCHEMBL13494614 0.86 ALDH1A1 (0.38) ENPP2CYP3A4TSHRHTR2BCHRM1
SCHEMBL448143 0.78 CA2 (0.43) TSHRCA2LPLLIPGRAPGEF4
SCHEMBL13084437 0.76 CYP3A4 (0.48) ENPP2CYP3A4HTR2BCHRM1ALOX15
SCHEMBL624402 0.75 CYP3A4 (0.43) ENPP2CYP3A4NOX1TSHRHTR2B
SCHEMBL29825793 0.75 CYP3A4 (0.43) ENPP2CYP3A4NOX1TSHRHTR2B
SCHEMBL21459591 0.74 ACHE (0.39) CA2LPLLIPGRAPGEF4ALOX5
SCHEMBL28836922 0.74 CA2 (0.35) ENPP2CA2LPLLIPG
SCHEMBL3656240 0.74 CA2 (0.40) CYP3A4TSHRCA2LPLLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698517-A1 <SUP2/>? <SUB2/>?4?NOVEL COMPOUNDS AS ?? <NS1:SUB>7</NS1:SUB>?INHIBITORS Evotec International GmbH (DE) 2026-02-25 EP disclosed
US-20250026766-A1 Thiazolopyridyl Amide Derivatives as DNA Polymerase Theta Inhibitors BEIGENE, LTD. (KY) 2025-01-23 US disclosed
EP-4463456-A1 THIAZOLOPYRIDYL AMIDE DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS BeiGene, Ltd. (KY) 2024-11-20 EP disclosed
WO-2024218058-A1 NOVEL COMPOUNDS AS α4β7 INHIBITORS EVOTEC INTERNATIONAL GMBH (DE) 2024-10-24 WO disclosed
CN-118510778-A Thiazolopyridylamide derivatives as inhibitors of DNA polymerase θ 百济神州有限公司 2024-08-16 CN disclosed
WO-2023134708-A1 THIAZOLOPYRIDYL AMIDE DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS BEIGENE , LTD. (KY) 2023-07-20 WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
WO-2020130664-A1 ORGANIC LUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DIODE USING SAME 두산솔루스 주식회사 2020-06-25 WO disclosed
WO-2020130664-A1 ORGANIC LUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DIODE USING SAME 두산솔루스 주식회사 2020-06-25 WO disclosed
US-10160745-B2 Piperidine and azepine derivatives as prokineticin receptor modulators TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-12-25 US disclosed
US-8507688-B2 Process for preparing aryl- and heteroarylacetic acid derivatives BAYER CROPSCIENCE AG (DE) 2013-08-13 US disclosed
WO-2011089072-A1 METHOD FOR PRODUCING ARYL AND HETEROARYLACETIC ACID DERIVATIVES BAYER CROPSCIENCE AG (DE) 2011-07-28 WO disclosed
US-20110184180-A1 Process for Preparing Aryl- and Heteroarylacetic Acid Derivatives BAYER CROPSCIENCE AG (DE) 2011-07-28 US disclosed
US-7754103-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2010-07-13 US disclosed
US-7732021-B2 Liquid crystalline medium MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-06-08 US disclosed
US-7635505-B2 Liquid Crystalline Medium MERCK PATENT GMBH (DE) 2009-12-22 US disclosed
US-20090194738-A1 Liquid-crystalline medium MANABE ATSUTAKA 2009-08-06 US disclosed
US-20080277623-A1 Liquid Crystalline Medium MERCK PATENT GMBH (DE) 2008-11-13 US disclosed
US-20080128653-A1 Liquid Crystalline Medium MERCK PATENT GMBH (DE) 2008-06-05 US disclosed
US-20070135497-A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient ISHIHARA SANGYO KAISHA LTD. (JP) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080277623-A1 Liquid Crystalline Medium CHRM1, NEFM, CCNT1 ENPP2 2276/4885CYP3A4 2777/4885NOX1 2365/4885
US-10160745-B2 Piperidine and azepine derivatives as prokineticin receptor modulators GIPR, PROKR1, PROKR2 ENPP2 1696/4885CYP3A4 1968/4885NOX1 4820/4885
US-20110184180-A1 Process for Preparing Aryl- and Heteroarylacetic Acid Derivatives DDC, DDT, PAH ENPP2 1382/4885CYP3A4 84/4885NOX1 4026/4885
US-20250026766-A1 Thiazolopyridyl Amide Derivatives as DNA Polymerase Theta Inhibitors POLQ, POLK, POLI ENPP2 3159/4885CYP3A4 1564/4885NOX1 2750/4885
US-20070135497-A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient DDT, HCN1, HCN2 ENPP2 1978/4885CYP3A4 2206/4885NOX1 1731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.